Ca(2+)/calmodulin-dependent protein kinase II promotes cell cycle progression by directly activating MEK1 and

Nan Li1, Chunmei Wang1, Yanan Wu1

  • 1Institute of Immunology and National Key Laboratory of Medical Immunology, Second Military Medical University, Shanghai 200433, China.

Insights

Calcium/calmodulin-dependent protein kinase II (CaMKII) activates MEK/ERK signaling, leading to p27 protein degradation and promoting cell cycle progression in colon cancer cells. This reveals a novel cross-talk mechanism between CaMKII and MAPK pathways in cell cycle regulation.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Cancer Research

Background:

  • Cell proliferation relies on integrated signaling pathways including MAPK, PI3K, PKC, and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII).
  • Previous work identified hCaMKIINalpha as a CaMKII-inhibitory protein that suppresses tumor growth by arresting the cell cycle via p27 stabilization and MEK/ERK deactivation.
  • The precise mechanisms of cross-talk between CaMKII and MAPK signaling in cell cycle regulation remain unclear.

Purpose of the Study:

  • To elucidate the mechanistic details of the interplay between CaMKII and MAPK signaling pathways in regulating cell cycle progression.
  • To investigate the role of CaMKII in activating MEK/ERK signaling and its downstream effects on p27.
  • To provide mechanistic evidence for the cross-talk between CaMKII and MAPK signaling in colon adenocarcinoma cells.

Main Methods:

  • Investigated CaMKII activation of MEK/ERK signaling in colon adenocarcinoma cells.
  • Utilized in vitro assays to examine CaMKII binding to and phosphorylation of MEK1.
  • Assessed the interaction and phosphorylation of p27 by ERK2.

Main Results:

  • CaMKII activates MEK/ERK signaling, which phosphorylates and degrades p27, promoting cell cycle progression from S to G2/M phase.
  • CaMKII directly binds to and phosphorylates MEK1 in vitro, an effect inhibited by CaMKII inhibitors.
  • ERK2 directly interacts with and phosphorylates p27.

Conclusions:

  • This study demonstrates for the first time that CaMKII interacts with MEK1 and regulates p27 phosphorylation, impacting cell cycle progression.
  • Established mechanistic evidence for cross-talk between CaMKII and MAPK signaling pathways.
  • Highlights the convergence of CaMKII and MAPK signaling through MEK/ERK activation in controlling cell cycle progression.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...